Following this line, by crossing to KC mice and analyzing transposon insertions in the resulting tumors, it has been described a large number of candidate genes that may promote tumor progression in KrasG12D initiated pancreatic tumors namely TGF-β and p16/CDKN2A. This evidence concerns the gene CDKN2A and pancreatic neoplasm.